首页> 美国卫生研究院文献>Translational Psychiatry >DNA methylation as a putative mechanism for reduced dendritic spine density in the superior temporal gyrus of subjects with schizophrenia
【2h】

DNA methylation as a putative mechanism for reduced dendritic spine density in the superior temporal gyrus of subjects with schizophrenia

机译:DNA甲基化作为精神分裂症患者颞上回降低树突棘密度的推测机制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Reduced dendritic spine density (DSD) in cortical layer 3 of the superior temporal gyrus (STG), and multiple other brain regions, is consistently observed in postmortem studies of schizophrenia (SZ). Elucidating the molecular mechanisms of this intermediate phenotype holds promise for understanding SZ pathophysiology, identifying SZ treatment targets and developing animal models. DNA methylation (DNAm), the addition of a methyl group to a cytosine nucleotide, regulates gene transcription and is a strong candidate for such a mechanism. We tested the hypothesis that DNAm correlates with DSD in the human STG and that this relationship is disrupted in SZ. We used the Illumina Infinium HumanMethylation450 Beadchip Array to quantify DNAm on a genome-wide scale in the postmortem STG from 22 SZ subjects and matched non-psychiatric control (NPC) subjects; DSD measures were available for 17 of the 22 subject pairs. We found DNAm to correlate with DSD at more sites than expected by chance in NPC, but not SZ, subjects. In addition, we show that the slopes of the linear DNAm-DSD correlations differed between SZ and NPC subjects at more sites than expected by chance. From these data, we identified 2 candidate genes for mediating DSD abnormalities in SZ: brain-specific angiogenesis inhibitor 1-associated protein 2 (BAIAP2) and discs large, Drosophila, homolog of, 1 (DLG1). Together, these data suggest that altered DNAm in SZ may be a mechanism for SZ-related DSD reductions.
机译:在精神分裂症的验尸研究中,始终观察到颞上回(STG)皮质层3和其他多个大脑区域的树突棘密度(DSD)降低。阐明这种中间表型的分子机制为理解SZ病理生理学,确定SZ治疗目标和开发动物模型提供了希望。 DNA甲基化(DNAm)是在胞嘧啶核苷酸上添加一个甲基基团,可调节基因转录,是此类机制的强有力候选者。我们检验了DNAm与人类STG中的DSD相关并且在SZ中这种关系被破坏的假设。我们使用Illumina Infinium HumanMethylation450 Beadchip Array在来自22名SZ受试者和相匹配的非精神病控制(NPC)受试者的死后STG中以全基因组规模对DNAm进行了定量;在22个对象对中的17个对象中,DSD度量可用。我们发现DNAm与DSD相关的位点多于NPC(而非SZ)受试者偶然发现的位点。此外,我们显示线性DNAm-DSD相关性的斜率在SZ和NPC受试者之间的位置比偶然预期的要多。从这些数据中,我们确定了2个用于介导SZ中DSD异常的候选基因:脑特异性血管生成抑制剂1相关蛋白2(BAIAP2)和大盘,果蝇,1的同源物(DLG1)。总之,这些数据表明,SZ中DNAm的改变可能是SZ相关DSD降低的机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号